ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 74 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,593,000 | -28.1% | 850,000 | 0.0% | 0.41% | -13.6% |
| Q2 2015 | $3,604,000 | +9.8% | 850,000 | 0.0% | 0.48% | -5.5% |
| Q1 2015 | $3,281,000 | -51.2% | 850,000 | -15.0% | 0.51% | -51.2% |
| Q4 2014 | $6,730,000 | +22.6% | 1,000,000 | 0.0% | 1.04% | -8.1% |
| Q3 2014 | $5,490,000 | -23.5% | 1,000,000 | +42.9% | 1.13% | -40.6% |
| Q2 2014 | $7,175,000 | -20.3% | 700,000 | -6.7% | 1.90% | -8.2% |
| Q1 2014 | $9,008,000 | +6.2% | 750,000 | 0.0% | 2.07% | -15.9% |
| Q4 2013 | $8,483,000 | – | 750,000 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |